Picture of Stratec SE logo

SBS Stratec SE Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Stratec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line25.24029.215.416
Depreciation
Deferred Taxes
Non-Cash Items4.910.416.37.9111.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-21.1-5.95-50.7-22.9-0.26
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities31.863.510.319.348.7
Capital Expenditures-25.6-20.2-19-17.3-18.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3.740.1050.022-26.72.22
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-21.8-20.1-19-44.1-16
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.22-34.3-14.135.4-20.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash14.99.62-24.510.913.6